Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
Paul Thompson MD
Paul D. Thompson MD Advisory Board
See All Experts
featured
Published in Cardiology and
1 other channel

Journal Scan / Research · November 11, 2020

Lower Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban vs Warfarin in Patients With AF

Circulation: Cardiovascular Quality and Outcomes

 

 Save  Recommend
 Share

Additional Info

Circulation: Cardiovascular Quality and Outcomes
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial
Circ Cardiovasc Qual Outcomes 2020 Nov 05;[EPub Ahead of Print], K Vilain, H Li, WJ Kwong, EM Antman, CT Ruff, E Braunwald, DJ Cohen, RP Giugliano, EA Magnuson,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated